|
ZNF700 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5261299999958E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.574480E-04 |
| Normal-vs-Stage2 |
2.202100E-04 |
| Normal-vs-Stage3 |
2.22109999999942E-05 |
| Normal-vs-Stage4 |
6.562600E-04 |
| Stage1-vs-Stage2 |
2.965400E-01 |
| Stage1-vs-Stage3 |
1.349160E-01 |
| Stage1-vs-Stage4 |
3.504400E-01 |
| Stage2-vs-Stage3 |
9.372400E-01 |
| Stage2-vs-Stage4 |
9.333000E-01 |
| Stage3-vs-Stage4 |
8.651800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8207999999964E-06 |
| Normal-vs-AfricanAmerican |
9.664300E-03 |
| Normal-vs-Asian |
1.047210E-01 |
| Caucasian-vs-AfricanAmerican |
8.041200E-01 |
| Caucasian-vs-Asian |
3.509900E-02 |
| AfricanAmerican-vs-Asian |
2.877800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.475100E-03 |
| Normal-vs-Female |
1.49069999999529E-06 |
| Male-vs-Female |
9.420200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.158500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.55102999999102E-05 |
| Normal-vs-Age(61-80Yrs) |
1.793320E-04 |
| Normal-vs-Age(81-100Yrs) |
2.291800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.607450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.890800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.738400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.524400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.953800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.701600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.557200E-04 |
| Classical-VS-Follicular |
2.719200E-01 |
| Classical-VS-Other |
7.076400E-01 |
| Classical-VS-Normal |
3.835800E-04 |
| Tall-VS-Follicular |
2.127700E-02 |
| Tall-VS-Other |
2.029400E-01 |
| Tall-VS-Normal |
2.4470000004051E-07 |
| Follicular-VS-Other |
4.828600E-01 |
| Follicular-VS-Normal |
2.448300E-04 |
| Other-VS-Normal |
3.402600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25589999999221E-05 |
| Normal-vs-N1 |
1.499720E-03 |
| N0-vs-N1 |
7.796800E-01 |
|
|
